A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer
Year: 2015
Type: article
Study design: Clinical Trial
Source: Clinical Breast Cancer
Authors: Neil M. Iyengar, Monica N. Fornier, Steven M. Sugarman, Maria Theodoulou, Tiffany A. Troso-Sandoval, Gabriella M. D'Andrea, Pamela R. Drullinsky, Devika Gajria, Shari B. Goldfarb, Elizabeth A. Comen, Diana E. Lake, Shanu Modi, Tiffany A. Traina, Mario E. Lacouture, Melanie F. Chen, Sujata Patil, José Baselga, Larry Norton, Clifford A. Hudis, Chau T. Dang
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: Cancer Center Support Grant
OpenAlex ID: W1761383249